Oxford Biomedica PLC
20 April 2006
Oxford BioMedica plc (the 'Company')
Holdings in Company
The Company was notified on 20 April 2006 by Calyon Corporate and Investment
Bank that following recent purchases, on 19 April 2006 Credit Agricole Cheuvreux
International Ltd had an interest in 48,708,932 Oxford BioMedica plc 1p ordinary
shares. This represents approximately 9.75% of the current issued share capital
of the Company.
These shares are registered in the name of Credit Agricole Cheuvreux
International Ltd. By virtue of section 203 of the Companies Act 1985, the
following companies also have an interest in the shares:
Credit Agricole SA
Calyon SA
Credit Agricole Cheuvreux SA
SAS Rue La Boetie
The Company was also notified on 20 April 2006 by Man Financial Limited that
following recent sales, on 19 April 2006 Man Financial Limited had an interest
in 17,094,597 Oxford BioMedica plc 1p ordinary shares, representing
approximately 3.42% of the current issued share capital of the Company.
20 April 2006
Andrew Wood
Chief Financial Officer
Tel 01865 783000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.